A new study says older diabetes patients would benefit from wearing glucose monitors, Baring Private Equity Asia is to buy Lumenis, over half of UK SMEs are ‘unprepared’ for Brexit despite further delay, and a UK AI company receives FDA clearance.
NICE recommends Bayer’s MS treatment, complementary cancer therapies ‘do more harm than good’, Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial, and could greater collaboration accelerate much-needed treatments for children with rare diseases?
The designer of a Parkinson’s diagnosis pen signs a five-year manufacture deal, Scottish Enterprise grants medtech firm EnMovi £2.5m, the NHS Digital toolkit now allows logins for approved digital health and care app developers, and a post-Brexit trade panel is to feature at next week's Arab Health.
Eli Lilly completes its takeover of Dermira, Novartis and the NHS strike an ‘innovative’ cardiovascular deal, GSK’s CEO hopes to get six new drug approvals in the next year, and Aberdeen University’s Elasmogen announces it’s secured follow-on equity investment.
The UK’s drug regulator is using VR to train staff on GMP standards, the UK and South Korea to fund a major consortium focused on tackling severe asthma, healthy habits could deliver an ‘extra disease-free decade’, and 9,000 nurses in Northern Ireland begin their strike.
There's a look back at 2019’s biggest breakthroughs in medical science, an ‘impossible’ machine offering new hope to cancer patients, a report on how Google answered the top 10 health questions, and Boris Johnson’s plans to speed up clinical trials.
The RCN announces their new Chair of the College’s ruling council, England’s top doctors warn many are at risk of flu this season, there’s a look at how 2019 shaped community pharmacies, and medical leaders call for an end to the stalemate at Northern Ireland’s Stormont.
The ABHI teams up with ITN to explore the impact of tech on healthcare services, a COPD treatment receives CE marking, an NHS hospital begins using robotics in knee surgery, and UK cancer patients now have access to a treatment allowing clinicians to see the position and size of tumours in real time.
Celltrion Healthcare receive EU approval for their Remsima drug, Astellas purchases a gene therapy company for $3 billion, the ABPI recruit internally for their new CEO, could a ‘liquid health check’ predict disease risk, and has uncertainty lead to pharma innovation?
The BMA takes legal action against NHS Property Services over ‘unjustifiable’ rises in service charges, the NHS encourages its staff to get the free flu jab, the Conservative manifesto pledges to add 50,000 nurses in England by 2024-25, and NHS orthopaedic hospitals trial a support app.